A Guide To The Risks Of Investing In Integra Lifesciences Holdings Corp (IART)

Daniel Torres

Integra Lifesciences Holdings Corp’s recent filing unveils that its Director GRAVES JEFFREY A acquired Company’s shares for reported $0.1 million on Nov 05 ’25. In the deal valued at $11.35 per share,9,000 shares were bought. As a result of this transaction, GRAVES JEFFREY A now holds 41,086 shares worth roughly $0.51 million.

Then, Schwartz Eric sold 4,070 shares, generating $100,102 in total proceeds. Upon selling the shares at $24.59, the EVP, Chief Legal Officer & Sec now owns 59,511 shares.

Before that, Schwartz Eric bought 4,070 shares. Integra Lifesciences Holdings Corp shares valued at $100,102 were divested by the Officer at a price of $24.59 per share.

Argus upgraded its Integra Lifesciences Holdings Corp [IART] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in early December with a ‘”an Underweight”‘ rating. BTIG Research also remained covering IART and has increased its forecast on October 07, 2024 with a “Neutral” recommendation from previously “Sell” rating. Citigroup revised its rating on July 30, 2024. It rated IART as “a Sell” which previously was an “a Neutral”.

Price Performance Review of IART

On Tuesday, Integra Lifesciences Holdings Corp [NASDAQ:IART] saw its stock jump 1.23% to $12.33. Over the last five days, the stock has gained 9.12%. Integra Lifesciences Holdings Corp shares have fallen nearly -51.67% since the year began. Nevertheless, the stocks have fallen -45.63% over the past one year. While a 52-week high of $27.13 was reached on 01/30/25, a 52-week low of $10.87 was recorded on 11/05/25.

Levels Of Support And Resistance For IART Stock

The 24-hour chart illustrates a support level at 12.03, which if violated will result in even more drops to 11.74. On the upside, there is a resistance level at 12.59. A further resistance level may holdings at 12.86.

How much short interest is there in Integra Lifesciences Holdings Corp?

A steep rise in short interest was recorded in Integra Lifesciences Holdings Corp stocks on 2025-10-31, growing by 0.66 million shares to a total of 6.9 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 6.24 million shares. There was a rise of 9.58%, which implies that there is a positive sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.